Search within:  

Sort results by:      



1-20 of 51   Next >
 
1.  
Optimal excision margins for primary cutaneous melanoma. 2011 Feb (revised 2013 Feb). NGC:010262
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Pembrolizumab for advanced melanoma not previously treated with ipilimumab. 2015 Nov 25. NGC:010860
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma. 2014 Oct. NGC:010571
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 2012 Jul 9. NGC:009201
American Society of Clinical Oncology - Medical Specialty Society; Society of Surgical Oncology - Medical Specialty Society. View all guidelines by the developer(s)
5.  
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. 2012 Dec. NGC:009518
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. 2012 Dec. NGC:009517
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
7.  
Melanoma: assessment and management. 2015 Jul 29. NGC:010783
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8.  
Preoperative and pretreatment investigations for malignant melanoma. 2012 Mar (revised 2013 Feb). NGC:010264
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab. 2015 Oct 7. NGC:010817
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
10.  
Sentinel node biopsy in primary cutaneous melanoma. 2011 Feb (revised 2014 Feb). NGC:010344
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
11.  
Biopsy of a suspicious pigmented lesion. 2012 Mar (revised 2013 Feb). NGC:010248
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
12.  
Guidelines of care for the management of primary cutaneous melanoma. 2001 Mar (revised 2011 Nov). NGC:009038
American Academy of Dermatology - Medical Specialty Society. View all guidelines by the developer(s)
13.  
Systemic therapy for unresectable stage III or metastatic cutaneous melanoma. 2015 Aug. NGC:010882
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Adjuvant radiation for malignant melanoma. 2012 Mar. NGC:009386
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
15.  
Referral and follow-up surveillance of cutaneous melanoma. 2011 Feb (revised 2013 Feb). NGC:010266
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16.  
Adjuvant interferon for malignant melanoma. 2014 Feb. NGC:010377
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18.  
Management of resectable stage IV primary cutaneous melanoma without nodal disease. 2010 May (revised 2013 Feb). NGC:010260
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Management of in-transit disease of the limbs. 2010 May (revised 2013 Feb). NGC:010259
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions. 2015 Nov 11. NGC:010828
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-20 of 51   Next >